ABSTRACT The question of whether schools and colleges of pharmacy have an obligation to train their students in the use of artificial intelligence (AI) tools for clinical practice has gained increasing attention in recent years, particularly as AI platforms and access continue to evolve. To evaluate this responsibility, it is important to consider both the potential benefits of AI in advancing clinical practice and the risks associated with its integration into pharmacy education. This article represents the collaborative efforts of two Academic Leadership Fellows Program groups who explored each viewpoint during structured debate at the American Association of Colleges of Pharmacy Interim Meeting in Phoenix, AZ, in February 2024.
Nagel et al. (Sun,) studied this question.